BFC Planning’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
BFC Planning's DFTX Position: Q3 2026 in Review
BFC Planning reduced its Definium Therapeutics (DFTX) stake by 26% in Q3 2026, selling an estimated $288K and leaving 19,087 shares worth $765K. The position accounts for 0.03% of the portfolio, ranked #468.
BFC Planning first reported a position in DFTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.22M in Q2 2026. 253 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- BFC Planning held 19,087 shares of Definium Therapeutics worth $765K as of Q3 2026.
- BFC Planning sold 6,837 Definium Therapeutics shares in Q3 2026, an estimated $288K.
- Definium Therapeutics made up 0.03% of BFC Planning's portfolio in Q3 2026, its #468 holding.
- BFC Planning first reported a position in Definium Therapeutics in Q3 2024 and has held it in 8 quarters since.
- BFC Planning's Definium Therapeutics position peaked at $1.22M in Q2 2026.
- 253 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.